Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Gliosarcoma × Albumin-Bound Paclitaxel × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Pancreatic Neoplasms 34 Breast Neoplasms 11 Carcinoma, Non-Small-Cell Lung 10 Neoplasms 9 Neoplasm Metastasis 8 Lung Neoplasms 4 Esophageal Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Sarcoma 3 Breast Neoplasms, Male 3 Adenocarcinoma 3 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Stomach Neoplasms 2 Small Cell Lung Carcinoma 2 Recurrence 2 Pancreatic Diseases 2 Metastatic Pancreatic Adenocarcinoma 2 Melanoma 2 Carcinoma 2 Advanced Solid Tumor 2 Tongue Neoplasms 1 Thymus Neoplasms 1 Solid Cancer 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Prostatic Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic cancer, adult 1 Ovarian Neoplasms 1

Interventions

Temozolomide 22 Radiotherapy 14 Radiation 7 Bevacizumab 6 Erlotinib Hydrochloride 5 Carmustine 5 Carboplatin 5 Radiotherapy, Conformal 4 Everolimus 4 temsirolimus 3 Vorinostat 3 Sirolimus 3 Radiotherapy, Intensity-Modulated 3 Irinotecan 3 tipifarnib 2 plerixafor 2 atezolizumab 2 Surgical Procedures, Operative 2 Gefitinib 2 Fluorodeoxyglucose F18 2 Cilengitide 2 veliparib 1 vatalanib 1 vandetanib 1 terameprocol 1 tandutinib 1 romidepsin 1 picropodophyllin 1 pembrolizumab 1 pamiparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04528680 2025-07-31

SC9/ABX

Northwestern University

Phase 1/2 Active not recruiting

Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡